
Circular mRNA CAR-T: Does the Data Support a Shift from Linear Designs?
Researchers propose a 'scarless' circular mRNA platform designed to improve the stability of CAR-T therapies. Pre-clinical data indicates superior durability and antitumour activity compared to standard linear mRNA, though human efficacy remains unproven.
By Hu, Zhao, Zhou, Tian, Wang, Hua, Zhang

